Novavax, Inc. (NVAX)
8.12
-0.42
(-4.92%)
USD |
NASDAQ |
Apr 10, 16:00
8.04
-0.08
(-0.99%)
Pre-Market: 08:35
Novavax Free Cash Flow : -251.02M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 12.36B |
| Pfizer Inc. | 9.076B |
| Moderna, Inc. | -2.075B |
| Intellia Therapeutics, Inc. | -395.86M |
| Recursion Pharmaceuticals, Inc. | -380.44M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -39.48M |
| Cash from Investing (Quarterly) | 20.48M |
| Cash from Financing (Quarterly) | -6.604M |
| Free Cash Flow Per Share (Quarterly) | -0.2526 |
| Free Cash Flow to Equity (Quarterly) | -68.63M |
| Free Cash Flow to Firm (Quarterly) | -36.02M |
| Free Cash Flow Yield | -18.12% |